MSCs mediate long-term efficacy in a Crohn's disease model by sustained anti-inflammatory macrophage programming via efferocytosis.
Saved in:
| Title: | MSCs mediate long-term efficacy in a Crohn's disease model by sustained anti-inflammatory macrophage programming via efferocytosis. |
|---|---|
| Authors: | Dave M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, UC Davis Medical Center, University of California Davis School of Medicine, Sacramento, CA, USA. mdave@ucdavis.edu.; Institute for Regenerative Cures, University of California Davis School of Medicine, Sacramento, CA, USA. mdave@ucdavis.edu., Dev A; Division of Gastroenterology and Hepatology, Department of Internal Medicine, UC Davis Medical Center, University of California Davis School of Medicine, Sacramento, CA, USA., Somoza RA; Skeletal Research Center, Department of Biology, Case Western Reserve University, Cleveland, OH, USA., Zhao N; Division of Gastroenterology and Liver Disease, University Hospitals, Case Western Reserve University, Cleveland, OH, USA., Viswanath S; Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA., Mina PR; Division of Gastroenterology and Hepatology, Department of Internal Medicine, UC Davis Medical Center, University of California Davis School of Medicine, Sacramento, CA, USA., Chirra P; Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA., Obmann VC; Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Mahabeleshwar GH; Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH, USA., Menghini P; Division of Gastroenterology and Liver Disease, University Hospitals, Case Western Reserve University, Cleveland, OH, USA., Durbin-Johnson B; Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Sacramento, CA, USA., Nolta J; Institute for Regenerative Cures, University of California Davis School of Medicine, Sacramento, CA, USA.; Division of Malignant Hematology/Cell and Marrow Transplantation, Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, USA., Soto C; Division of Gastroenterology and Hepatology, Department of Internal Medicine, UC Davis Medical Center, University of California Davis School of Medicine, Sacramento, CA, USA., Osme A; Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH, USA., Khuat LT; Department of Dermatology, University of California Davis School of Medicine, Sacramento, CA, USA., Murphy WJ; Division of Malignant Hematology/Cell and Marrow Transplantation, Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, USA.; Department of Dermatology, University of California Davis School of Medicine, Sacramento, CA, USA., Caplan AI; Skeletal Research Center, Department of Biology, Case Western Reserve University, Cleveland, OH, USA., Cominelli F; Division of Gastroenterology and Liver Disease, University Hospitals, Case Western Reserve University, Cleveland, OH, USA. |
| Source: | NPJ Regenerative medicine [NPJ Regen Med] 2024 Jan 20; Vol. 9 (1), pp. 6. Date of Electronic Publication: 2024 Jan 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group, published in partnership with Monash University and Australian Regenerative Medicine Institute Country of Publication: United States NLM ID: 101699846 Publication Model: Electronic Cited Medium: Internet ISSN: 2057-3995 (Electronic) Linking ISSN: 20573995 NLM ISO Abbreviation: NPJ Regen Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2057-3995 |
|---|---|
| DOI: | 10.1038/s41536-024-00347-1 |
